News
Steve Collis’ three decades of experience at a major drug distributor could prove helpful for Elevance as it continues to ...
The board of directors of Elevance Health (NYSE: ELV) announced today that Steve Collis, a highly regarded global healthcare executive, will be joining the company’s board, effective August 1. He will ...
Steven Collis (Courtesy of JNF-USA) Steven Collis is the CEO of AmerisourceBergen, a publicly-traded drug wholesale company with 2021 revenues of more than $200 billion. The Jewish Haverford resident ...
Steven Collis, Chairman, President & CEO of Cencora Inc (NYSE:COR), sold 10,754 shares of the company on April 16, 2024, according to a recent SEC filing. The transaction was executed at an ...
STEVE COLLIS: I think when we get into vaccines, Steve, it’s somewhat complicated because it is an unusual pharmaceutical channel. There’s so many different points of access and where it gets ...
AmerisourceBergen's (ABC) CEO Steve Collis on Q2 2020 Results - Earnings Call Transcript May 07, 2020 2:30 PM ET Cencora, Inc. (COR) Stock COR SA Transcripts 153.81K Follower s ...
Amerisourcebergen Corp (ABC) CEO Steven Collis on Q3 2022 Results - Earnings Call Transcript Aug. 03, 2022 11:51 AM ET Cencora, Inc. (COR) Stock COR SA Transcripts 153.35K Follower s ...
STEVEN COLLIS: Our purpose-driven culture continues to empower our associates. MANN: AmerisourceBergen set Collis' total compensation for 2020 at more than $14 million, which means Collis got a 25 ...
By Reuters January 19, 20181:14 PM UTCUpdated ago Jan 19 (Reuters) - AmerisourceBergen Corp: * AMERISOURCEBERGEN CORP SAYS CEO STEVEN COLLIS' FY 2017 TOTAL COMPENSATION WAS $9.9 MILLION VERSUS $10 ...
Specifically, 48% of the stockholders rejected the compensation given to CEO Steve Collis and his management team, an outcome that suggests the company misjudged investor sentiment about the pay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results